Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Opthea ( (AU:OPT) ) has shared an update.
Opthea Limited has announced that its Annual General Meeting will be held on November 11, 2025. The company has set September 23, 2025, as the deadline for director nominations, which must be submitted in writing. This announcement is part of Opthea’s ongoing corporate governance practices and may impact the company’s board composition and strategic direction.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
Opthea Limited is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases. The company is listed on both the Australian Securities Exchange (ASX) and NASDAQ, indicating its international market focus.
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
For detailed information about OPT stock, go to TipRanks’ Stock Analysis page.